Quad-C Management, a leading middle market private equity firm, today announced that it has closed an investment in Inmark Packaging, a leading distributor of rigid container and life sciences packaging. While specific terms have not been disclosed, the deal was structured as an owner-operator recapitalization, allowing the company’s management to retain a significant ownership in the business.
Based in Atlanta, Georgia, Inmark Packaging is a leading global provider of packaging solutions, with locations in North America, Europe and Asia. Founded in 1975, the company primarily distributes rigid container packaging, and designs and distributes life sciences packaging solutions for specimen transport, temperature-controlled and dangerous goods applications. Inmark also provides online dangerous goods regulatory compliance training.
“After vetting numerous potential partners, we selected Quad-C due to their industry expertise as well as their historical success in partnering with owner-operators like myself,” said David Oyler, CEO of Inmark. “We have completed three acquisitions in the past three years, and we felt bringing on a partner like Quad-C, with substantial capital, industry and M&A expertise, would allow us to accelerate growth further.”
“David and his management team have done an excellent job building out the Inmark platform in recent years, and we’re looking forward to supporting their organic and acquisition-driven growth strategies going forward,” added Frank Winslow, Partner at Quad-C Management.
In addition to representing another successful owner-operator recapitalization, the Inmark Packaging transaction falls squarely within three of Quad-C’s core investing sectors -- packaging, specialty distribution and healthcare. Some of Quad-C’s past investments in these sectors include: Technimark, a global provider of injection molded solutions serving consumer packaging, healthcare and specialty industrial end markets; EFC, a leading value-added distributor of specialty fasteners to the automotive and industrial end-markets; and Joerns Healthcare, a leading manufacturer of equipment and provider of wound therapy solutions for the care and handling of patients in post-acute healthcare settings.
Source : finance.yahoo.com